Open AccessDasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
Author(s) -
Ahmet Emre Eşkazan,
Teoman Soysal
Publication year - 2013
Publication title -
turkish journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.351
H-Index - 16
ISSN - 1300-7777
DOI - 10.4274/tjh.2013-0013
Subject(s) - dasatinib , medicine , myeloid leukemia , protein kinase domain , imatinib , cancer research , mutation , oncology , genetics , mutant , gene , biology